Stock listing
NASDAQ:PDLI PDL BioPharma Inc Stock
Follow PDL BioPharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PDLI
$2.47 USD
Close on Jan 6, 2021 · No longer trades
- Lowest – highest close
- $1.98 – $40.57 USDSince Oct 10, 2001 · lowest Dec 20, 2016 · highest Dec 6, 2001
Delisted NASDAQ:PDLI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PDLI
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
PDL BioPharma Inc on 6ix
- Decks
- 130 decks · latest Nov 13, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2020 Earnings Presentation | Earnings | 13 slides | Nov 13, 2020 |
| Investor Presentation (September 2020) | Investor deck | 32 slides | Sep 10, 2020 |
| Q2 2020 Earnings Presentation | Earnings | 17 slides | Aug 6, 2020 |
| Investor Presentation (July 2020) | Investor deck | 30 slides | Jul 17, 2020 |
| Q1 2020 Earnings Presentation | Earnings | 15 slides | May 7, 2020 |
| Q4 2019 Earnings Presentation | Earnings | 16 slides | Mar 11, 2020 |
| Proxy Contest (January 2020) | Proxy contest | 19 slides | Jan 15, 2020 |
| Q3 2019 Earnings Presentation | Earnings | 14 slides | Nov 6, 2019 |
| Investor Presentation (October 2019) | Investor deck | 30 slides | Oct 21, 2019 |
| Cantor Fitzgerald Global Healthcare Conference 2019 | Conference | 26 slides | Oct 3, 2019 |
Show 50 decks
This page holds 50 of 130 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Faheem Hasnain Other companies: Aspen Neuroscience, Inc. (Aspen Executive Chairman · Since at least Nov 2, 2026); Gossamer Bio, Inc. (Co-Founder, Chairman, and Chief Executive Officer · Since at least Feb 7, 2019); Kura Oncology, Inc. (Lead Independent Director · Since at least Apr 23, 2015); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Immunic, Inc. (Director · Aug 11, 2016 – Sep 13, 2018 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – Nov 10, 2014 · Past); Receptos Inc (President & CEO, Director · May 8, 2013 – Aug 25, 2015 · Past); Somaxon Pharmaceuticals Inc (Director · Sep 16, 2010 – Dec 31, 2012 · Past); Facet Biotech Corp (President & CEO, Director · Dec 9, 2008 – Apr 21, 2010 · Past) | President & CEO, Director · Oct 1, 2008 – Oct 1, 2008 · Past |
| Herb Cross Other companies: Jasper Therapeutics, Inc. (Chief Financial Officer · Since at least Sep 22, 2023); Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past); Atreca Inc (Chief Financial Officer · Jun 19, 2019 – Aug 2, 2023 · Past); Armo Biosciences Inc. (Chief Financial Officer · Jan 25, 2018 – Jun 22, 2018 · Past); Humanigen Inc (Chief Financial Officer · Oct 22, 2013 – Nov 9, 2015 · Past); Affymax Inc (Chief Financial Officer · Nov 15, 2010 – Jan 30, 2013 · Past); Facet Biotech Corp (VP of Finance · Dec 9, 2008 – Apr 21, 2010 · Past); Neoforma Inc (VP of Finance · Dec 31, 2005 – Dec 31, 2005 · Past) | Corp Controller/Prin Acctg Off · Jun 20, 2007 – Sep 15, 2008 · Past |
| Shlomo Yanai Other companies: Philip Morris International Inc (Director · Since at least May 5, 2021); Amneal Pharmaceuticals, Inc. (Director · Since at least Dec 14, 2019); W. R. Grace & Co (Director · May 9, 2018 – Sep 22, 2021 · Past); Exela Technologies, Inc. (Director · Jul 12, 2017 – Jul 12, 2017 · Past); Perrigo Company plc (Director · Nov 4, 2015 – May 19, 2016 · Past); Sagent Pharmaceuticals Inc (Director · Apr 15, 2015 – Aug 29, 2016 · Past); Protalix BioTherapeutics, Inc. (de) (Director · Jul 24, 2014 – Jul 24, 2014 · Past); Cambrex Corporation (Director · Nov 28, 2012 – Dec 4, 2019 · Past) | Director · Jun 8, 2018 – Jun 20, 2019 · Past |
| Steven E Benner Other companies: CTi Biopharma Corp (EVP, Chief Medical Officer · Jun 13, 2012 – Mar 21, 2013 · Past) | SVP & Chief Med. Off. · Jul 16, 2006 – Jul 20, 2006 · Past |
| Bruce Tomlinson | Chief Financial Officer · Jun 11, 2012 – Jun 21, 2012 · Past |
| Caroline J Krumel | VPFinance/Prin.Accting Officer · Jan 31, 2011 – Jan 18, 2012 · Past |
| Laurence Jay Korn | Director · Jan 3, 2006 – May 28, 2008 · Past |
| Paul W Sandman | Director · Jun 8, 2018 – Jun 20, 2019 · Past |
Log in to ask 6ix AI your own questions about PDL BioPharma Inc.